Heart Murmur Hints Cancer—Years Early

Medical professionals in an operating room monitoring a patient

Your heart may be sending a cancer warning years before any tumor shows up — and a cardiac MRI scan could be the decoder ring.

Story Snapshot

UCLA researchers found that subtle heart structural changes, called cardiac remodeling, are linked to higher future cancer risk in a study of more than 4,500 patients.
Higher heart muscle mass was tied to increased breast cancer risk, while reduced left atrial function was linked to higher colorectal cancer risk.
The study tracked participants for years and found 790 new cancer cases, with cancer rates rising as heart remodeling worsened.
Researchers stress this shows an association, not a cause — the heart changes do not directly cause cancer.

What UCLA Found in the Heart Scans

A UCLA Health research team studied cardiac MRI data from more than 4,500 patients and found a clear pattern. People whose hearts showed early structural changes were more likely to develop certain cancers later. The strongest link was between higher left ventricular mass — that is, a thicker, heavier heart muscle — and breast cancer risk. A weaker but still significant left atrium, measured by something called peak left atrial strain, was tied to a higher risk of colorectal cancer. As those heart measurements got worse, cancer rates went up.^[1]

The findings appeared in the Journal of the American Heart Association. Lead author Dr. Xinjiang Cai, a cardiologist at UCLA Health, put it plainly: “Structural and functional changes in the heart may occur alongside — or even before — biological processes linked to cancer development.” That is a significant statement. It suggests the heart may be acting as an early warning system for a disease most people associate with genetics or lifestyle alone.^[1]

This Is Not the First Time UCLA Pointed to the Heart-Cancer Link

This MRI study is actually the second major finding from the same UCLA research program. An earlier study, published in the Journal of the American College of Cardiology: Advances, found that tiny elevations in two blood-based heart markers — high-sensitivity cardiac troponin T, which detects heart muscle injury, and a peptide called NT-proBNP, which signals heart stress — were strong predictors of overall cancer risk. Both markers were tied to higher colorectal cancer risk, and NT-proBNP alone was linked to higher lung cancer risk, even in people with no known heart disease.^[3]

Taken together, these two studies point in the same direction. The heart, it seems, reflects something deeper happening in the body — a shared biological environment where both cardiovascular disease and cancer can take root. Inflammation, metabolic stress, and cellular damage may drive both conditions at the same time, long before either shows obvious symptoms.^[3]

What the Researchers Are Careful Not to Claim

Dr. Cai was direct about the limits of the findings. “These findings represent associations and do not establish causation,” he said. A thicker heart muscle does not cause breast cancer. A weaker left atrium does not cause colorectal cancer. What the data show is that these two things tend to happen in the same people over time. That is meaningful, but it is not a green light to start ordering cardiac MRIs as cancer screening tools.^[1]

UCLA-led research suggests early heart changes may predict future cancer risk
MRI-detected ‘cardiac remodeling’ was linked to higher risks of breast and colorectal cancers years before diagnosis

⁦⁦⁦@DOM_UCLA⁩ ⁦⁦@UofCAHealth⁩ https://t.co/WHnEsfD9LU

— Xinjiang Cai, MD, PhD 🫀 (@XinjiangCai) June 13, 2026

This distinction matters for patients and doctors alike. Observational studies like this one — where researchers follow a group of people and record what happens — can reveal important patterns. But they cannot rule out other explanations. A third factor, like chronic inflammation or obesity, could be driving both the heart changes and the cancer risk at the same time. Larger studies with external validation are needed before these markers become part of standard cancer risk assessment.^[15]

Why This Research Direction Makes Practical Sense

Here is what makes this finding worth paying attention to, even at this early stage. Cardiac MRI is already used widely to assess heart failure risk. The imaging tools exist. The measurements are already being taken for millions of patients. If those same scans can also flag elevated cancer risk — without any additional cost or procedure — that is an enormous potential benefit. Dr. Cai noted that “imaging markers already used to identify people at risk for cardiovascular disease may also help identify people at elevated risk for cancer.”^[1]

That kind of dual-purpose diagnostic thinking is exactly where medicine should be heading. Rather than treating every organ system in isolation, researchers are starting to map the connections between them. The heart and cancer biology share more common ground than most people realize, and that overlap could eventually point toward earlier interventions that save lives on both fronts. The research is early, but the direction is sound and worth watching closely.^[3]